Is there an association between anti-TNF monoclonal antibody therapy in rheumatoid arthritis and risk of malignancy and serious infection? Commentary on the meta-analysis by Bongartz et al

Will Dixon, Alan Silman

    Research output: Contribution to journal › Article › peer-review

    Fingerprint

    Dive into the research topics of 'Is there an association between anti-TNF monoclonal antibody therapy in rheumatoid arthritis and risk of malignancy and serious infection? Commentary on the meta-analysis by Bongartz et al'. Together they form a unique fingerprint.

    Nursing and Health Professions

    Pharmacology, Toxicology and Pharmaceutical Science